𝔖 Bobbio Scriptorium
✦   LIBER   ✦

243 ADDITIVE CYTOTOXIC EFFECTS OF GEFITINIB (ZD1839) IN COMBINATION WITH ANTICANCER DRUGS IN HUMAN PROSTATE CANCER CELL LINES

✍ Scribed by U. Treiber; A. Kaspin; H. Kubier; A. Lehmer; R. Paul; J. Gschwend; N. Zantl; H. Van Randenborgh

Book ID
119617575
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
317 KB
Volume
6
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tumor inhibitory effect of gefitinib (ZD
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231)
✍ Daisuke Takabatake; Takeo Fujita; Tadahiko Shien; Kensuke Kawasaki; Naruto Taira πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 588 KB

## Abstract Some kinds of breast cancer cell lines, similar to several types of solid tumors, express epidermal growth factor receptor (EGFR). However, gefitinib, an EGFR tyrosine kinase inhibitor, is not effective for all these cell lines. Similarly, taxane is effective for many of the cell lines,